It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
[Pharmacoeconomic analysis of dabigatran etexilate effectiveness in patients with nonvalvular atrial fibrillation].
https://arctichealth.org/en/permalink/ahliterature127345
Source
Kardiologiia. 2012;52(1):44-51
Publication Type
Article
Date
2012
More detail
Author
Iu B Belousov
V Iu Mareev
I S Iavelov
D Iu Belousov
E V Afanas'eva
Source
Kardiologiia. 2012;52(1):44-51
Date
2012
Language
Russian
Publication Type
Article
Keywords
Anticoagulants - economics - therapeutic use
Aspirin - economics - therapeutic use
Atrial Fibrillation - complications - economics
Benzimidazoles - economics - therapeutic use
Blood Coagulation - drug effects
Blood Coagulation Tests - methods
Costs and Cost Analysis - methods - statistics & numerical data
Humans
Insurance, Pharmaceutical Services - statistics & numerical data
Models, Statistical
Outcome and Process Assessment (Health Care) - methods - statistics & numerical data
Pyridines - economics - therapeutic use
Russia
Thromboembolism - blood - drug therapy - economics - etiology
Ticlopidine - administration & dosage - analogs & derivatives - economics
PubMed ID
22304352
View in PubMed
Less detail
Permalink